Categories: 
Pharmaceutical
Report Id: PGEM117

The global genome editing market is rapidly increasing due to the increased government funding for genomics technology, rise in the production of genetically modified crops and technological advancements these all factors are driving the growth of this market.
 
Recent developments across genome editing technologies have resulted in the creation of next generation nucleases that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases.
 
Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generation’s therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment.
 
This market research report categorizes the genome editing market into the following segments: 
 
By Technology 
•    CRISPR/CAS9 
•    TALENs 
•    ZFNs 
•    Antisense Technology 
•    Other Technologies 
 
By Application 
•    Cell Line Engineering 
•    Animal Genetic Engineering 
•    Plant Genetic Engineering 
•    Other Applications 
 
By End User
•    Biotechnology and Pharmaceutical Companies 
•    Government and Academic Research Institutes 
•    Other Research Organizations
  
By Geographical Region
•    North America 
•    Europe 
•    Asia 
•    Rest of the World 

1 INTRODUCTION    
    1.1    KEY TAKE AWAYS    
    1.2    REPORT DESCRIPTION    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5    RESEARCH METHODOLOGY    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES    
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES 

2 Research Methodology 
    2.1 Research Methodology Steps 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
           2.2.2 Primary Research
                     2.2.2.1 Key Data From Primary Sources
                     2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology 
           2.3.1 Market Data Validation and Triangulation
           2.3.2 Assumptions for the Study

3 Executive Summary 
    3.1 Introduction 
    3.2 Conclusion

4 Premium Insights 
    4.1 Genome Editing: Market Overview 
    4.2 Geographic Analysis: Genome Editing Market, By Application (2016) 
    4.3 Market Size, By Technology, 2016 vs 2021 
    4.4 Market Size, By Application, 2016 vs 2021 
    4.5 Market Size, By End User, 2016 vs 2021 
    4.6 Geographical Snapshot of the Genome Editing Market

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                     5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                     5.2.1.2 High Prevalence Rate of Infectious Diseases and Cancer Among Patients
                     5.2.1.3 Technological Advancements
                     5.2.1.4 Increase in Demand for Synthetic Genes
                     5.2.1.5 Rise in Production of Genetically Modified Crops
                     5.2.1.6 Increasing Awareness About Genomics
                     5.2.1.7 New Product Launches By Industry Players
           5.2.2 Restraints
                     5.2.2.1 High Cost of Genomic Equipment
                     5.2.2.2 Adverse Public Perception Related to Genetic Research
           5.2.3 Opportunities
                     5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
                     5.2.3.2 Emerging Markets in Developing Countries
           5.2.4 Challenges
                     5.2.4.1 Off-Target Effect of CRISPR
                     5.2.4.2 Shortage of Trained Professionals

6 Global Genome Editing/Engineering Market, By Technology 
    6.1 Introduction 
    6.2 CRISPR 
    6.3 TALEN 
    6.4 ZFN 
    6.5 Antisense 
    6.6 Other Technologies

7 Global Genome Editing/Genome Engineering Market, By Application 
    7.1 Introduction 
    7.2 Cell Line Engineering 
    7.3 Animal Genetic Engineering 
    7.4 Plant Genetic Engineering 
    7.5 Other Applications

8 Global Genome Editing/Engineering Market, By End User
    8.1 Introduction 
    8.2 Biotechnology & Pharmaceutical Companies 
    8.3 Academic & Government Research Institutes 
    8.4 Contract Research Organizations

9 Genome Editing/Genome Engineering Market, By Region 
    9.1 Introduction 
    9.2 North America 
           9.2.1 U.S.
                     9.2.1.1 Development of Gene Therapy in the U.S.
                     9.2.1.2 Increasing Use of Gm Crops
                     9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States
                     9.2.1.4 Genome Editing Conferences in the U.S.
                     9.2.1.5 Rising Availability of Research Grants and Funding
                     9.2.1.6 Genome Editing Standards Workshop in the U.S.
                     9.2.1.7 Increasing Prevalence of Cancer
                     9.2.1.8 Strategic Developments in the U.S. Market
           9.2.2 Canada
                     9.2.2.1 Availability of Research Funding in Canada
                     9.2.2.2 Rising Incidence of Cancer
                     9.2.2.3 Gapp to Intensify Genomic R&D
    9.3 Europe 
           9.3.1 Conferences and Meetings in Europe
           9.3.2 U.K.
                     9.3.2.1 Increased Funds, and Grants By Government Bodies
                     9.3.2.2 100,000 Genomes Project in U.K.
           9.3.3 Germany
                     9.3.3.1 Availability of Funding for Life Science Research
                     9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany
                     9.3.3.3 RoE
                     9.3.3.4 Spain’s Focus on Research
                     9.3.3.5 Growth in the Italian Biotech and Pharma Sectors
                     9.3.3.6 Growing Research Investments in Sweden & Denmark
    9.4 Asia-Pacific 
           9.4.1 China
                     9.4.1.1 High Intensity of R&D Activities in China
                     9.4.1.2 Growing Focus of Global Companies on China
           9.4.2 Japan
                     9.4.2.1 Involvement of Industry Players in the Japanese Market: Significant Developments
                     9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
                     9.4.2.3 Focus on Cancer Research and Treatment
           9.4.3 India
                     9.4.3.1 Emergence of Local Players in India
                     9.4.3.2 Growth of the Pharmaceutical Industry in India
                     9.4.3.3 Development of Bio-Clusters to Boost India’s Biotechnology Industry
           9.4.4 RoAPAC
                     9.4.4.1 Australia: Availability of Financial Support for Research
                     9.4.4.2 Genome Asia 100k Initiative
                     9.4.4.3 Crop Research Initiatives in Asia
    9.5 RoW 
           9.5.1 Genetic Testing and Genomic Analysis in the Middle East
           9.5.2 Brazil: Investments in Research and Innovation Centers and Conferences & Workshops
           9.5.3 Rising Prevalence of Hiv, Cancer in Africa

10 Competitive Landscape 
     10.1 Overview 
     10.2 Market Share Analysis 
               10.2.1 Introduction
               10.2.2 Thermo Fisher Scientific, Inc.
               10.2.3 Merck KGaA
               10.2.4 Horizon Discovery Group PLC
     10.3 Competitive Situation and Trends 
               10.3.1 Agreements, Collaborations, and Partnerships
               10.3.2 Product & Service Launches
               10.3.3 Acquisitions
               10.3.4 Expansions
               10.3.5 Other Strategies
     10.4 Strategic Benchmarking

11 Company Profiles 

     11.1 Thermo Fisher Scientific, Inc. 
     11.2 Merck KGaA 
     11.3 Horizon Discovery Group PLC  
     11.4 Genscript USA Inc. 
     11.5 Sangamo Biosciences, Inc. 
     11.6 Integrated DNA Technologies, Inc. 
     11.7 Lonza Group Ltd. 
     11.8 New England Biolabs, Inc. 
     11.9 Origene Technologies, Inc. 
     11.10 Transposagen Biopharmaceuticals, Inc.
 

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 

Email: Sales@marketresearchengine.com

Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204